PIK3CA and endometrial cancer: Advanced, inoperable metastatic and/or recurrent solid tumors, ovarian or endometrial cancer.Enrolment criteria for endometrial cancer: AKT1, PIK3CA, or PIK3R1 mutations with or without PTEN deficiency